Quick Answer
AVITA Medical, Inc. reported Gross Profit of $58.82 million for the year ending 2025.
- AVITA Medical, Inc. showed an increase of +6.6% in Gross Profit from 2024 to 2025.
- This data is from AVITA Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $37.0 thousand | Q4 2018: $798.0 thousand | Q1 2019: $1.42 million | Q2 2019: $1.95 million | Q3 2019: $2.63 million | Q4 2019: $2.41 million | Q1 2020: $3.24 million | Q2 2020: $3.00 million | Q3 2020: $4.13 million | Q4 2020: $4.28 million | Q1 2021: $6.62 million | Q2 2021: $8.25 million | Q3 2021: $5.93 million | Q1 2022: $5.76 million | Q2 2022: $6.95 million | Q3 2022: $7.56 million | Q1 2023: $8.88 million | Q2 2023: $9.55 million | Q3 2023: $11.53 million | Q1 2024: $9.59 million | Q2 2024: $13.08 million | Q3 2024: $16.36 million | Q1 2025: $15.68 million | Q2 2025: $14.95 million | Q3 2025: $13.88 million.
- Over the full 8 years of available data (2018 to 2025), AVITA Medical, Inc.'s Gross Profit has grown by 15,256.7%.
- Historical annual values: Fiscal year 2025: $58.82 million | Fiscal year 2024: $55.16 million | Fiscal year 2023: $42.36 million | Fiscal year 2022: $28.38 million | Fiscal year 2021: $23.28 million | Fiscal year 2020: $11.29 million | Fiscal year 2019: $4.20 million | Fiscal year 2018: $383.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: